About Us
Giovannelli e Associati is an independent law firm, which combines an international approach with solid local roots.
We provide high profile corporate and finance legal advice, with a distinctive and innovative approach.
What differentiates us?
We are a cohesive team of lawyers with more than 10 years of experience together in some of the leading Italian and international law firms.
We are a cohesive team of lawyers with more than 10 years of experience together in some of the leading Italian and international law firms.
We focus first on satisfying our clients’ needs and on delivering solutions for their problems.
"Sources highlight the firm's client commitment and confirm that "they are a very good firm in Italy.” - Chambers Europe 2018
"Sources emphasise the team's availability to clients, with one stating: "It is a boutique law firm which is very flexible and able to provide constant access to partners.” - Chambers Europe 2018
"They have a wealth of experience in private equity matters including M&A, LBOs and venture capital.” - Chambers Europe 2017
“Good-quality lawyers that are dynamic and proactive." - Chambers Europe 2017
"A very motivated group of lawyers." "The firm exceeded my expectations"
Chambers Europe 2016
"They always focus on targets and have a wide range of competences".
IFLR1000 2016
"A business-oriented team with a client-friendly and proactive approach. The lawyers come up with ideas that go outside the boundaries of the specific legal aspects of a transaction, which is very helpful"
Chambers Europe 2015
"I was incredibly happy. It was smooth sailing, what I would expect from a much larger firm."
Chambers Europe 2015
17/04/2018
Giovanelli e Associati has been ranked in Legal 500 for Commercial, Corporate and M&A, Private Equity, Banking and Finance and Capital Markets areas. In addition, Legal […]
05/04/2018
Eugenio Romita mentioned by Who’s Who Legal as one of the most relevant tax lateral hire in 2017. Read More: Who’s Who Legal – ER
04/04/2018
Giovannelli e Associati advised Genextra, a biotech group holding, on the Italian tax aspects of the mid-term loan of USD 80 million granted by Credit Suisse […]